Topological quantum processor marks breakthrough in computing
Peer-Reviewed Publication
Updates every hour. Last Updated: 29-Apr-2025 22:08 ET (30-Apr-2025 02:08 GMT/UTC)
In a leap forward for quantum computing, a Microsoft team led by UC Santa Barbara physicists on Wednesday unveiled an eight-qubit topological quantum processor, the first of its kind. The chip, built as a proof-of-concept for the scientists’ design, opens the door to the development of the long-awaited topological quantum computer.
After a cyber attack or natural disaster, a backup network of decentralized devices — like residential solar panels, batteries, electric vehicles, heat pumps, and water heaters — could restore electricity or relieve stress on the grid, MIT engineers find.
Paxlovid does not significantly reduce COVID-19 hospitalization and mortality among vaccinated older adults. The study questions the assumption that Paxlovid’s effectiveness in reducing COVID-19 hospitalizations and deaths in unvaccinated adults also applies to vaccinated adults.
A new study evaluates three distinct algorithms—Band Shape Fitting (BSF), Three-band Fraunhofer Line Discrimination (3FLD), and Singular Vector Decomposition (SVD)—to retrieve far-red solar-induced chlorophyll fluorescence (SIF) diurnal patterns from tower-based observations.
Systems engineering researchers have developed a new technique to improve the efficiency of food-delivery operations. The technique accounts for the location of food distribution sites and delivery locations to develop optimized delivery routes that make food delivery faster and more fuel efficient.
Researchers identify predictive markers of response to immunotherapy treatment in a study involving data from over 700 patients across six different cohorts, published in Nature Communications. The study has significant relevance, impacting the management of bladder cancer patients. Machine learning tools enabled the identification of key variables for the success of immunotherapy treatment. This innovative methodology has allowed researchers to pinpoint which tumor subtypes respond best to immunotherapy.